A COST-EFFECTIVENESS ANALYSIS OF ADJUVANT PEMBROLIZUMAB IN THE TREATMENT OF PATIENTS WITH EARLY-STAGE (STAGES IB-III) NON-SMALL CELL LUNG CANCER (NSCLC) FOLLOWING COMPLETE RESECTION AND PLATINUM-BASED CHEMOTHERAPY

被引：0
|
作者：
Draganigos, A. [1 ]
Nguyen, S. [1 ]
Skroumpelos, A. [2 ]
Iliopoulou, E. [2 ]
Mylonas, C. [2 ]
Karokis, A. [2 ]
机构：
[1] MSD Greece, Athens A1, Greece
[2] MSD Greece, Alimos, Attica, Greece
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE192
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 50 条
  • [31] Sublobar resection in the treatment of elderly patients with early-stage non-small cell lung cancer
    Afonso, Margarida
    Branco, Carlos
    Alfaro, Tiago Manuel
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2020, 46 (04)
  • [32] Prognostic model in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy
    Radosavljevic, D. Z.
    Gavrilovic, D.
    Golubicic, I.
    Jelic, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] PROGNOSTIC IMPORTANCE OF RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Radosavljevic, D.
    Kezic, I.
    Jelic, S.
    Golubicic, I.
    ANNALS OF ONCOLOGY, 2008, 19 : 111 - 111
  • [34] COST-EFFECTIVENESS OF USING A PROGNOSTIC TEST TO GUIDE TREATMENT DECISIONS IN EARLY STAGE NON-SMALL CELL LUNG CANCER (NSCLC)
    Stenehjem, D.
    Bellows, B. K.
    Kaldate, R. R.
    Jones, J.
    Siebert, U.
    Brixner, D.
    VALUE IN HEALTH, 2014, 17 (03) : A89 - A89
  • [35] Elemene injection as adjunctive treatment to platinum-based chemotherapy in patients with stage III/IV non-small cell lung cancer: A meta-analysis following the PRISMA guidelines
    Wang Xuewei
    Liu Zhengtang
    Sui Xinbing
    Wu Qibiao
    Wang Jue
    Xu Cong
    PHYTOMEDICINE, 2019, 59
  • [36] Efficacy and safety of adjuvant alectinib vs platinum-based chemotherapy (CT) in patients (pts) from Asia with resected, early-stage ALK plus non-small cell lung cancer (NSCLC): A sub analysis of ALINA
    Ahn, J. S.
    Wu, Y-L.
    Dziadziuszko, R.
    Barlesi, F.
    Nishio, M.
    Lee, D. H.
    Lee, J-S.
    Zhong, W-Z.
    Horinouchi, H.
    Mao, W.
    Lu, S.
    Wang, Q.
    Yang, C-T.
    Korphaisarn, K.
    Xu, T.
    Bu, L.
    Scalori, A.
    Petric, P.
    Redhead, K.
    Solomon, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S1646 - S1647
  • [37] Platinum-based chemotherapy with thoracic radiotherapy in stage III good performance status non-small cell lung cancer patients
    Baka, S
    Faivre-Finn, C
    Papakotoulas, P
    Blackhall, F
    Anderson, H
    Lorigan, P
    Thatcher, N
    EJC SUPPLEMENTS, 2005, 3 (03): : 41 - 50
  • [38] Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC)
    Hainsworth, John D.
    Waterhouse, David M.
    Shih, Kent C.
    Boccia, Ralph, V
    Priego, Victor M.
    McCleod, Michael J.
    Kudrik, Fred J.
    Mitchell, Reed Brian
    Burris, Howard A., III
    Greco, F. Anthony
    Spigel, David R.
    LUNG CANCER, 2018, 118 : 6 - 12
  • [39] Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC)
    Lee, SW
    Choi, EK
    Chung, WK
    Shin, KH
    Ahn, SD
    Kim, JH
    Kim, SW
    Suh, C
    Lee, JS
    Kim, WS
    Kim, DS
    Kim, DK
    Park, SI
    Sohn, KH
    LUNG CANCER, 2002, 37 (01) : 65 - 71
  • [40] Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer
    Thatcher, N
    Faivre-Finn, C
    Blackhall, F
    Anderson, H
    Lorigan, P
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5051S - 5056S
12345